Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Coherus BioSciences, Inc.”

73 pharma patents match "Coherus BioSciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 73
Index total 30,257
Page 1 / 4

Quick answer

This filtered view shows 73 pharmaceutical patents matching "Coherus BioSciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

73 results for “Coherus BioSciences, Inc.” · 30,257 patents in full index Clear search

  1. US 11667702

    Stable aqueous formulations of aflibercept

    Coherus BioSciences, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted

  2. US 11583584

    Stable protein compositions and methods of their use

    Coherus BioSciences, Inc. · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  3. US 11576971

    Method of filling a container with no headspace

    Coherus BioSciences, Inc. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

  4. US 11426446

    Stable aqueous formulations of aflibercept

    Coherus BioSciences, Inc. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  5. US 11400072

    Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

    Coherus BioSciences, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  6. US 11396540

    Methods for making recombinant proteins

    Coherus BioSciences, Inc. · Granted Jul 26, 2022 · Expires Jul 21, 2042

    granted

  7. US 11253508

    PPARy agonist for treatment of progressive supranuclear palsy

    Coherus BioSciences, Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  8. US 11229702

    High concentration formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  9. US 11135267

    Etanercept formulations stabilized with metal ions

    Coherus BioSciences, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  10. US 11129876

    Etanercept formulations stabilized with amino acids

    Coherus BioSciences, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  11. US 11071782

    Method of filling a container with no headspace

    Coherus BioSciences, Inc. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted

  12. US 11001627

    Correctly folded etanercept in high purity and excellent yield

    Coherus BioSciences, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted

  13. US 11000588

    Etanercept formulations stabilized with sodium chloride

    Coherus BioSciences, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted

  14. US 10987405

    Method of reducing formation of etanercept aggregates or fragments

    Coherus BioSciences, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted

  15. US 10980884

    Stable aqueous etanercept composition

    Coherus BioSciences, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  16. US 10980885

    Method of reducing formation of etanercept aggregates or fragments

    Coherus BioSciences, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  17. US 10975138

    Correctly folded etanercept composition

    Coherus BioSciences, Inc. · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  18. US 10954293

    Correctly folded etanercept in high purity and excellent yield

    Coherus BioSciences, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  19. US 10954294

    Correctly folded etanercept in high purity and excellent yield

    Coherus BioSciences, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  20. US 10954295

    Correctly folded etanercept in high purity and excellent yield

    Coherus BioSciences, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  21. US 10947306

    Correctly folded etanercept in high purity and excellent yield

    Coherus BioSciences, Inc. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted

  22. US 10888619

    Stable aqueous etanercept composition

    Coherus BioSciences, Inc. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted

  23. US 10822429

    Etanercept formulations exhibiting marked reduction in sub-visible particles

    Coherus BioSciences, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  24. US 10799585

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.